Ascendis Pharma A/S

ASND

$194.30

Name : Ascendis Pharma A/S

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $11,765,720,064.00

EPSttm : -5.28

Ascendis Pharma A/S

$194.30

0.78%

$1.50

Float Short %

4.58

Margin Of Safety %

Put/Call OI Ratio

1.36

EPS Next Q Diff

0.98

EPS Last/This Y

5.13

EPS This/Next Y

5.44

Price

194.3

Target Price

249.89

Analyst Recom

Performance Q

21.4

Relative Volume

0.65

Beta

0.38

Ticker: ASND

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-07-25	ASND	167.49	1.34	0.10	7154
2025-07-28	ASND	164.37	1.34	0.05	7173
2025-07-29	ASND	163.25	1.40	0.02	7041
2025-07-30	ASND	167.72	1.39	0.44	7050
2025-07-31	ASND	173.49	1.34	0.06	7299
2025-08-01	ASND	174.18	1.11	1.13	7912
2025-08-04	ASND	184.21	1.10	0.49	7885
2025-08-05	ASND	186.59	0.90	0.60	10236
2025-08-06	ASND	182.89	0.79	6.41	13321
2025-08-07	ASND	190.34	0.78	5.98	14929
2025-08-08	ASND	191.53	0.80	1.09	15297
2025-08-11	ASND	195.79	0.85	0.39	15475
2025-08-12	ASND	195.91	0.85	0.58	15450
2025-08-13	ASND	190.81	0.85	7.80	15456
2025-08-14	ASND	192.02	0.87	301.40	15577
2025-08-15	ASND	198.34	0.96	0.39	16333
2025-08-18	ASND	194.01	1.11	0.01	8481
2025-08-19	ASND	194.3	1.34	2.20	7795
2025-08-20	ASND	191.92	1.34	1.11	7811
2025-08-21	ASND	193.8	1.35	0.15	7864
2025-08-22	ASND	194.13	1.36	0.06	7850
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-07-25	ASND	167.47	31.5	117.8	-3.71
2025-07-28	ASND	164.65	31.5	120.5	-3.71
2025-07-29	ASND	163.32	31.5	117.6	-3.71
2025-07-30	ASND	166.78	31.5	111.5	-3.71
2025-07-31	ASND	173.50	31.4	107.2	-3.72
2025-08-01	ASND	174.48	31.4	115.6	-3.72
2025-08-04	ASND	184.15	31.4	104.2	-3.72
2025-08-05	ASND	186.59	31.4	114.0	-3.72
2025-08-06	ASND	182.77	31.4	120.6	-3.72
2025-08-07	ASND	190.35	31.4	105.9	-3.72
2025-08-08	ASND	191.49	31.4	114.6	-3.72
2025-08-11	ASND	195.87	62.8	-36.9	-2.81
2025-08-12	ASND	195.77	84.4	59.1	-2.28
2025-08-13	ASND	191.08	82.7	62.7	-2.44
2025-08-14	ASND	191.76	82.7	58.5	-2.44
2025-08-15	ASND	198.20	82.7	54.3	-2.39
2025-08-18	ASND	194.32	82.7	61.9	-2.39
2025-08-19	ASND	194.62	82.7	58.5	-2.39
2025-08-20	ASND	192.71	84.3	60.3	-2.46
2025-08-21	ASND	192.96	84.3	58.7	-2.46
2025-08-22	ASND	194.30	84.3	57.7	-2.46
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-07-25	ASND	0.00	1.60	4.55
2025-07-28	ASND	0.00	1.52	4.55
2025-07-29	ASND	0.00	1.52	4.55
2025-07-30	ASND	0.00	1.52	4.55
2025-07-31	ASND	0.00	1.52	4.55
2025-08-01	ASND	0.00	1.52	4.55
2025-08-04	ASND	0.00	1.29	4.55
2025-08-05	ASND	0.00	1.29	4.55
2025-08-06	ASND	0.00	1.29	4.55
2025-08-07	ASND	0.00	1.29	4.55
2025-08-08	ASND	0.00	1.29	4.55
2025-08-11	ASND	0.00	1.26	4.54
2025-08-12	ASND	0.00	1.26	4.58
2025-08-13	ASND	0.00	1.26	4.58
2025-08-14	ASND	0.00	1.26	4.58
2025-08-15	ASND	0.00	1.26	4.58
2025-08-18	ASND	0.00	0.40	4.58
2025-08-19	ASND	0.00	0.40	4.58
2025-08-20	ASND	0.00	0.40	4.58
2025-08-21	ASND	0.00	0.40	4.58
2025-08-22	ASND	0.00	0.40	4.58
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.93

Avg. EPS Est. Current Quarter

-0.27

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

Institutional Transactions

0.4

Beta

0.38

Average Sales Estimate Current Quarter

209

Average Sales Estimate Next Quarter

262

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

2.8

Max Drawdown 5-Year %

-61.7

Target Price

249.89

P/E

Forward P/E

48.09

PEG

P/S

22.01

P/B

P/Free Cash Flow

EPS

-4.97

Average EPS Est. Cur. Y

-2.46

EPS Next Y. (Est.)

2.98

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-54.94

Relative Volume

0.65

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

1.1

EBIT Estimation

57.7

Ascendis Pharma A/S

Sector: Healthcare

Industry: Biotechnology

Employees: 1017

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

stock quote shares ASND – Ascendis Pharma A/S Stock Price stock today

news today ASND – Ascendis Pharma A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch ASND – Ascendis Pharma A/S yahoo finance google finance

stock history ASND – Ascendis Pharma A/S invest stock market

stock prices ASND premarket after hours

ticker ASND fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ASND

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y